Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich, Oxford BioMedica Settle Litigation with Open Biosystems

NEW YORK (GenomeWeb News) – Sigma-Aldrich and Oxford BioMedica said today that they have settled their two-year-old litigation with Open Biosystems over patents covering lentiviral vector technology.
Sigma-Aldrich and Oxford agreed to dismiss their suit against Open Bio, and Open Bio agreed to dismiss its counterclaims. As part of the settlement, Open Bio will acquire certain licensing rights to patents covering the use of Oxford’s LentiVector technology in research activities.
Other details of the settlement were not disclosed by the firms.
The dispute began in mid-2006, when Sigma-Aldrich and Oxford sued Open Bio for allegedly infringing two US patents held by Oxford and exclusively licensed by Sigma-Aldrich. In their lawsuit, the co-plaintiffs contend that numerous Open Bio products, including its RNAi Consortium shRNA lentiviral library and its shRNAmir libraries, infringed the IP.
As reported by GenomeWeb Daily News sister publication RNAi News in late February, the firms had been negotiating a potential settlement. The US District Court overseeing the case granted the companies’ request for “a stay of the litigation in all respects, including but not limited to expert disclosures … [through] March 14, 2008, to allow settlement talks to proceed.”

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.